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ABSTRACT
The purpose of the present study was to was to determine the pathogenic bacterial spectrum and bacterial 
antibiotic resistance in maxillofacial region of Belarussian patients. 
Materials and methods. The study comprised inpatient who were treated by maxillofacial surgeons during 
2014 in hospitals of Belarussian region: Brest, Mogilev, Vitebsk, Grodno and Gomel. It was a retrospec-
tive study, approval by the institution ethical committee. A microbiological sample was collected before 
antibiotic treatment. After meticulous disinfection of the skin around the planned extraoral incision site 
the aspiration of pus was attempted. If aspiration cannot be conducted, the samples were collected by 
swabbing the area after the incision and discharge of the pus. After sample collection, the material was 
immediately transported to the laboratory and further processed within 2 hours at the most. All speci-
mens were then tested for the prevalence of the predominant bacteria and their antibiotic susceptibility 
Results. At the present stage in Belarussian hospitals the main agents isolating from inflammatory fo-
cus of the maxillofacial region are streptococci, staphylococci, enterobacteria, that corresponds with 
the global data. On the basis of the major pathogen antibiotic resistance data the following antibiotics 
for initial therapy until the receiving the results of bacteriological tests can be recommended: clinda-
mycin (effective against all studied pathogenic species), ceftriaxone, fluoroquinolones (ciprofloxacin). 
Conclusions. It is necessary to conduct further systematic monitoring of microflora in patients with inflam-
matory diseases of maxillofacial area and studding the bacteria antibiotic resistance in order to improve 
the patient treatment efficiency.
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Introduction 
Odontogenic inflammatory disease of maxillofacial 
area is an infectious and inflammatory process arising 
from the microflora spread through the tooth root canal 
affected by caries and its complications, or periodontal 
pocket in periapical tissue [1]. For a long time it was 
thought that the microbial landscape with odontogenic 
infection is represented mainly by monoculture of Strep-
tococci or Staphylococci. According to the development 
of microorganism identification methods a lot of other 
microbial groups were studied and the role of gram-neg-
ative opportunistic pathogens was determined. Modern 
and advanced research technologies depend on the 
identification of genetic markers of microbial pathogens 
by polymerase chain reaction (PCR) [2]. 
Saprophytic microflora colonizing the mouth: Strep-
tococcus mutans, Streptococcus milleri, Peptostrepto-
coccus  spp., Fusobacterium spp., Actinomyces  spp. 
often appear as odontogenic infection agent. Nowadays 
more than 600 species of oral microorganisms were 
isolated and identified [3]. Microorganisms are usually 
localized on the oral cavity mucous membrane surface, 
in periodontal pockets, or decayed cavities [4]. Accord-
ing to the WHO classification the microflora of the oral 
cavity is mainly represented by anaerobic microbes 
growing in the dental plaque. Resident microflora of 
the oral cavity is extremely diverse, with low virulence 
properties [5] and includes bacteria, actinomycetes, 
fungi, protozoa, spirochetes, rickettsia, and viruses [6]. 
According to the contemporary professional literature 
in the field of odontogenic infectious-inflammatory pro-
cess associations of 2-6 microorganism species had been 
identified, e.g. facultative anaerobes (Streptococcaceae 
and Staphylococcaceae) and obligate anaerobes (Bac-
teroides, Fusobacteriaceae. Peptostreptococcaceae) [7]. 
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Different microorganisms may cause certain no-
sology. The development of odontogenic periostitis 
and osteomyelitis is caused by Staphylococcus aureus 
and Streptococcus spp., anaerobic flora (Peptococcus 
niger, Peptostreptococcus spp., Bacteroides spp.). 
Methicillin-sensitive Staphylococcus aureus (MSSA) is 
the main causative agent of nonodontogenic osteomy-
elitis in 52% cases, coagulase-negative staphylococci 
— 14 %, methicillin-resistant Staphylococcus aureus 
(MRSA) — 2 %, Pseudomonas aeruginosa — 4,4 %. 
Traumatic osteomyelitis is often caused by Staphylo-
coccus aureus, Enterobacteriaceae spp., Pseudomonas 
aeruginosa [7].
According to European researchers, in patients with 
odontogenic infection, the most frequently isolated 
bacteria were as follows: anaerobes (8%), gram-positive 
cocci (54 %), gram-negative cocci (8 %), Viridans group 
Streptococci (49 %), non-haemolytic Streptococci 
(11%), non-haemolytic Staphylococci (3 %), haemo-
lytic Streptococci (0,5 %), Enterecoccus spp. (1 %), 
Escherichia coli (1,5 %), Staphylococcus aureus (1 %), 
Bacteroides spp. (3 %) [8].
Thus, the causative agents of inflammatory dis-
eases of maxillofacial area are represented by various 
species of microorganisms, the odontogenic infection 
is characterized as polyetiological. Due to the devel-
opment of new microbiological methods, detection of 
the inflammatory disease etiology is expanding and 
updating constantly. All these facts indicate a need for 
further research in this direction.
Microbiological study of the maxillofacial inflamma-
tory disease causative agents allows the identification of 
the pathogenic bacteria and determine their sensitivity 
to chemotherapeutic drugs, though ultimately providing 
optimum medical and surgical treatment tactics.
Therefore, the aim of the present study was to 
retrospectively analyse the pathogenic bacterial spec-
trum and bacterial antibiotic resistance in Belarussian 
patients with maxillofacial inflammatory disease. 
Material and methods 
Study population
The study comprised patients, who were treated 
by maxillofacial surgeons in 2014 in hospitals of 
Belarussian region: Brest, Mogilev, Vitebsk, Grodno 
and Gomel. Patients with maxillofacial inflammatory 
disease accounted for 35% (238 people) of all pa-
tients hospitalized in the Maxillofacial Department 
in Brest, 38,5% (628 people) — n Grodno, 28% 
(727 people) — n Mogilev, 36% (669 people) — n 
Vitebsk. A total of 2920 people with maxillofacial 
inflammatory disease were treated in 5 Belarussian 
regional hospital in 2014. 
Inclusion criteria were odontogenic and nono-
dontogenic maxillofacial inflammatory process and 
no prior antibiotic treatment. Exclusion criterion was 
prior antibiotic treatment. All authors participating in 
the present study read the Declaration of Helsinki and 
the study was designed according to its guidelines. It 
was a retrospective study, approved by the local Ethics 
Committee. 
Data collection
The skin and the oral mucosa of the infected site 
were rinsed with antiseptic in order to disinfect surface 
before incision. A microbiological sample was collected 
before antibiotic treatment. After meticulous disinfection 
of the skin around the planned extraoral incision site the 
aspiration of pus was attempted. If aspiration could not 
be conducted, the samples were collected by swabbing 
the area after the incision and discharge of the pus. After 
sample collection, the material was immediately trans-
ported to the laboratory and further processed within 
2 hours at most. All specimens were then tested for 
the prevalence of the predominant bacteria and their 
antibiotic susceptibility [10–11]. The data was collected 
and analyzed in Microsoft Excell [12].
Results
Isolated bacteria
There were 65 isolates identified in the Department 
of Maxillofacial Surgery in Brest regional hospital. 
Staphylococci were isolated in most cases — 45 spe-
cies (70.0%), the most common group representative 
was Staphylococcus aureus. Enterobacteriaceae were 
presented by 7 strains (10.0%). Among them Escherich-
ia coli — 3 strains (4.0%) and Klebsiella pneumoniae 
— 2 strains (3.0%) were identified. Streptococcaceae 
were represented by Streptococcus pneumoniae 
— 11 strains (17.0%). Nonfermentative gram-negative 
rods (NFGNR) were represented by Acinetobacter 
baummanii — 2 strains (3.0%).
There were 799 isolates identified in the Depart-
ment of Maxillofacial Surgery in Mogilev regional 
hospital. Streptococci were isolated in most cases 
(30.2%) and were represented by Streptococcus 
viridans — 204 strains (26.0%), Streptococcus pneu-
moniae — 13 strains (1.6%), Streptococcus pyogenes 
— 21 strains (2.6%). Among coagulase-negative Staph-
ylococci (CNS) (43.0%) there were Staphylococcus 
epidermidis — 270 strains (35.0%) and Staphylococ-
cus saprophyticus — 66 strains (8.0%). Additionally, 
139 strains (17.0%) of Staphylococcus aureus were 
isolated. Enterococci (2.1%) were represented by En-
terococcus faecalis — 9 strains (1.0%), Enterococcus 
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faecium — 11 strains (1.1 %). Enterobacteriacae (2.72%) 
were represented by Klebsiella spp. — 14 strains 
(1.7%), Enterobacter spp.– 9 strains (1 %), Escherichia 
coli — 1 strain (0.02%). Pseudomonas spp. were repre-
sented by Pseudomonas aeruginosa — 6 strains (0.6%). 
There were 171 isolates identified in the Department 
of Maxillofacial Surgery in Gomel regional hospital. 
Streptococci were isolated in most cases (32.4%), repre-
sented by Streptococcus viridans — 25 strains (14.0%), 
Streptococcus pneumoniae — 3 strains (1.08%), Strep-
tococcus pyogenes — 10 strains (5.6%). There were 
50 strains (29.0%) of Staphylococcus aureus. CNS 
(21.6%) were identified as Staphylococcusepidermid-
is — 9 strains (5.0%), Staphylococcus saprophyticus 
— 8 strains (4.6%), Staphylococcus haemolyticus 
— 20 strains (12.0%). Enterobacteriacae (8.9%) were 
represented by Escherichia coli 7 (4.0%), Escherichia 
cloacae — 3 (1.8%), Citrobacter spp.– 1 (0.1%), Kleb-
siella spp. — 5 strains (3.0%). Enterococcus spp. was 
revealed in 1.8% cases — 3 strains. Members of the 
genus Pseudomonas were isolated in 3.0% of studies 
(5 strains). Other NFGNR were identified as Acineto-
bacter baummanii — 1 strain (0.1%).
There were 120 isolates identified in the Department 
of Maxillofacial Surgery in Vitebsk regional hospital. 
Staphylococci were isolated in most cases, among 
them Staphylococcus aureus — 18 strains (15.0%), CNS 
— 76 strains (63.5%). CNS were represented by Staph-
ylococcus epidermidis. Streptococci were revealed in 
8.3% of cases (10 strains). Enterobacteriacae (2.4%) 
were identified as Escherichia coli — 1 strain (0.8%) and 
Klebsiella pneumonia — 2 strains (1.6%). Pseudomonas 
Aeruginosa was isolated in 5.0% of studies (6 strains), 
Acinetobacter spp. — n 08 % (1 strain).
There were 162 isolates identified in the Department 
of Maxillofacial Surgery in Grodno regional hospital. 
Staphylococci were the most frequent bacteria detect-
ed — 139 strains (85.0%), among them Staphylococ-
cus aureus — 76 strains (47.0%), CNS — 63 strains 
(38.0%). CNS were represented by Staphylococcus 
epidermidis — 45 strains (28.0%), Staphylococcus 
haemolyticus — 12 strains (6.5%), Staphylococcus 
hominis — 3 strains (2.0%), Staphylococcus capitis 
— 2 strains (1.0%) and Stapylococcus warneri — 1 strain 
(0.5%). Enterobacteriacae were represented by 4 strains 
(2.0%), among them Klebsiella oxytoca — 1 strain 
(0.5%), Klebsiella pneumoniae — 1 strain (0.5%), 
Pseudomonas mirabilis — 2 strains (1.0%). There were 
11 strains (7.0%) of Streptococcaceae and they were 
represented by Streptococcus pyogenes — 3 strains 
(2.0%), Streptococcus mitis — 2 strains (1.0%), Strep-
tococcus sanguinis — 2 strains (1.0%), Streptococcus 
anginosus — 2 strains (1.0%) and Streptococcus pneu-
moniae — 2 strains (1.0%). NFGNR were represented 
by Acinetobacter — 1 strain (0.5%) and Pseudomonas 
aeruginosa — 1 strain (0.5%). Additionally, 1 strain of 
Enterococcus spp. (0.5%) was isolated. 
Antibiotic resistance
Antibiotic resistance of Staphylococcus aureus 
was studied in Departments of Maxillofacial Surgery in 
Vitebsk, Brest, Gomel and Mogilev regional hospitals. 
The greatest number of MRSA was detected in 
Brest — 27.8%. In Vitebsk this rate was 14.8%, in Mogi-
lev — 10.0%, and in Gomel — 5.6%. 
Staphylococcus aureus, isolated from the patients 
with maxillofacial inflammatory process in Vitebsk, was 
the least resistant to vancomycin (0%), clindamycin 
(0%), amikacin (3.7%), cefazolin (8.3%), ceftriaxone 
(11.5%), lincomycin (13.0%), gentamicin (14.8%), cip-
rofloxacin (18.5%), and ofloxacin (18.5%). The highest 
level of resistance was noted for cefotaxime (25.0%).
Staphylococcus aureus, isolated in Brest Department 
of Maxillofacial Surgery, was the least resistant to lome-
floxacin, vancomycin, gentamicin, ofloxacin, trimetho-
prim, pefloxacin (for all 0%), clindamycin (4.0%), linezolid 
(8.3%), tigecycline (16.7%), and levofloxacin (20.0%). 
The highest antibiotic resistance level of Staphylococcus 
aureus was revealed for erythromycin (71.4%). 
In the Department of Maxillofacial Surgery in Mogi-
lev regional hospital Staphylococcus aureus showed 
the least resistance to vancomycin (0%), clindamycin 
(5.0%), gentamicin (6.0%), levofloxacin (6.0%), the high-
est resistance level was detected for amoxicillin (85.0%). 
In the Department of Maxillofacial Surgery in Grodno 
regional clinical hospital Staphylococcus aureus did not 
demonstrate the resistance to vancomycin, gentamycin, 
levofloxacin (for all 0%). Resistance to linezolid was 
noted in 1.1% cases, clindamycine — 12.2%, erythro-
mycin — 17.8%.
The resistance of Staphylococcus aureus to antibiot-
ics differed in the studied Departments. The resistance 
of this pathogen to gentamycin was the lowest in Brest 
and Grodno (0%), in Mogilev regional hospital it was 
6.0% and in Vitebsk regional clinical hospital was the 
highest (14.8 %). Resistance of Staphylococcus au-
reus to clindamycin in Vitebsk was 0%, Brest — 4.0%, 
Mogilev — 5.0%, Grodno — 12.2%. Vancomycin re-
sistance of Staphylococcus aureus was not revealed 
in any hospital.
Based on our findings concerning antibiotic sen-
sitivity of Staphylococcus aureus in the Department 
of Maxillofacial Surgery of Brest, Vitebsk, Mogilev and 
Grodno regional clinical hospitals, clindamycin can be 
recommended as initial antibiotic therapy.
Gentamicin was effective against Staphylococcus 
aureus in Brest regional hospital and Grodno regional 
hospital. The sensitivity of Staphylococcus aureus to 
reserve antibiotic vancomycin was 100% in Vitebsk and 
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Mogilev. The highest number of MRSA was identified 
in the Department of Maxillofacial Surgery in Brest 
regional hospital. 
The highest number of methicillin-resistant strains 
of Staphylococcus epidermidis (MRSE) was detected 
in Grodno — 26.2%, in Vitebsk — 22.4%, in Mogi-
lev — 4.0%.
Staphylococcus epidermidis identified in the De-
partment of Maxillofacial Surgery in Vitebsk regional 
clinical hospital was the least resistant to vancomycin 
(0%), amikacin (9.4%), ciprofloxacin (11.5%), clindamy-
cin (14.0%), cefotaxime (14.4%), ceftriaxone (16.5%), 
cefazolin (16.6%), ofloxacin (18.4%), with the highest 
noted resistance to gentamicin (21.3%), and lincomycin 
(28.8%).
The least resistance of Staphylococcus epidermidis 
isolated in Grodno was to vancomycin, gentamicin and 
moxifloxacin (for all 0%). Resistance to levofloxacin 
amounted to 4.8%, to linezolid — 7.1%, to clindamy-
cin — 26.2%. 
Vancomycin resistance of Staphylococcus epi-
dermidis identified in the Department of Maxillofacial 
Surgery in Mogilev regional hospital was 0%, resistance 
to clindamycine was 6.0%, to gentamycin 8.0%, to 
levofloxacin 19.0%.
The resistance of Staphylococcus epidermidis to 
vancomycin was not detected  in the studied hospitals, 
the highest resistance to clindamicin was detected in 
Grodno, the highest resistance to gentamicin in Vitebsk.
In Gomel regional hospital Staphylococci antibiotic 
resistance accounted for vancomycin — 0%, doxy-
cycline — 3.3%, ciprofloxacin — 6.6%, clindamycine 
— 13.0%, penicillin — 50.0%. The number of methicil-
lin-resistant staphylococci was 23,1%.
Streptococci antibiotic resistance was identified 
in the Department of Maxillofacial Surgery in Vitebsk, 
Gomel, Brest. 
Streptococcus spp. isolated in the Department of 
Maxillofacial Surgery in Vitebsk regional hospital had the 
least resistance to clindamycin and vancomycin (for all 
0%), cefotaxime (4.0%), ceftriaxone (10.0%), ciprofloxa-
cin (13.3%), and doxycycline (20.0%). The higher level 
of resistance was identified for co-trimoxazole (24.0%), 
lincomycin (25.0%), and ampicillin (28.6 %). 
Streptococci identified in the Department of Max-
illofacial Surgery in Gomel regional hospital had no 
resistance to ceftriaxone, levofloxacin, doxycycline, 
amoxicillin/clavulanic acid (for all 0%). Resistance of 
Streptococci to clarithromycin amounted 3.4%, to oflox-
acin — 4.5%, to clindamycin — 5.2%, to ciprofloxacin 
— 5.6%, to tetracycline — 11.1%, to oxacillin — 15.4%. 
Streptococcus spp. identified in the Department of 
Maxillofacial Surgery in Brest regional hospital demon-
strated no resistance to ceftriaxone, erythromycin, 
levofloxacin (for all 0% resistant strains). Resistance to 
lincomycin, oxacillin, tetracycline was 12.5%, to eryth-
romycin — 50.0%. 
Enterobacterial antibiotic resistance was identified 
in the Department of Maxillofacial Surgery in Vitebsk, 
Gomel, Grodno. 
Enterobacteriaceae had no resistance to ceftazi-
dime, cetriaxone, cefotaxime, imipenem, meropenem, 
amikacin, gentamicin, ciprofloxacin, cefoperazone/sul-
bactam in Vitebsk regional hospital. Resistance to 
amoxicillin/clavulanic acid amounted 50.0%. The least 
resistance of Enterobacteriacea to imipenem (0%), 
amikacin (0%), ceftazidime (5.6%), ciprofloxacin (6.2%), 
ceftriaxone (17.6 %) was revealed in the Department of 
Maxillofacial Surgery in Gomel regional hospital. The 
highest resistance was detected for amoxicillin/clavulan-
ic acid (31.2%) and cefazolin (33.3%). In Grodno region-
al hospital Enterobacteriacea had the least resistance to 
amikacin, ceftazidime, cefotaxime, cefepime, imipenem, 
meropenem, levofloxacin, tazobactam, tobramycin 
(0%). Resistance to co-trimoxazole, ciprofloxacin and 
gentamicin was 9.1%, to piperacillin — 11.0%, to tet-
racycline, norfloxacin and amoxicillin/clavulanic acids 
— 25.0%, to penicillin — 40.0%.
Discussion
According to the modern researches the identified 
causative agents of maxillofacial inflammatory diseas 
are: Staphylococcus aureus — 26.7%, Staphylococcus 
epidermidis — 17.8%, Streptococcus spp. — 11.1%, 
Escherichia coli and Proteus spp. — 11.1% of cases. In 
another study conducted in the Clinic of Oral and Max-
illofacial Surgery in Nuremberg in 2010, Streptococci 
and Staphylococci were dominating among 40 identified 
aerobic bacterial cultures [13]. This data corresponds 
well with our results.
The study conducted by O. Ibragimov (2008) 
showed, that there are certain differences in the se-
lected wound microflora in children with infectious 
maxillofacialinflammatory disease. In the microflora 
Staphylococcus aureus was dominating (54.1%) and 
the share of Enterobacteriacae accounted for 37.8% of 
all isolated microorganisms. In addition, Candida albi-
cans was recorded — 2.7%; and even non-fermentative 
gram-negative rods (Pseudomonas aeruginosa) were 
determined — 5.4%. 
Therefore the results of microbiological testing of 
infectious maxillofacial inflammatory disease carried 
out in 5 Belarussian hospitals in 2014 were different. 
However, the general trend is that there is the main 
contribution of Streptococci and Staphylococci in the 
development of this disease.
According to the study of Staphylococci antibiotic 
resistance in the Department of Maxillofacial Surgery 
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in Vitebsk, Gomel, Mogilev, Brest and Grodno region-
al hospitals, there was no resistance to vancomycin 
— the antibiotic of choice for treating MRSA. This 
result corresponds with the data about the absence 
of vancomycin-resistant Staphylococcus spp. in the 
Republic of Belarus. Clindamycin, doxycycline (Gomel), 
gentamicin (Brest, Grodno) can be recommended as 
empiric, first-line antibiotic therapy of inflammatory 
diseases of maxillofacial area. MRSA was isolated in all 
5 hospitals. Identification of MRSA is associated with 
low effectiveness of beta-lactam antibiotics (penicillins, 
cephalosporins, carbapenems, combinations of peni-
cillins with beta-lactamase inhibitors).
Effective antibiotics for streptococcal infections of 
the maxillofacial region are clindamycin, ceftriaxone 
and fluoroquinolones (levofloxacin, ciprofloxacin). 
Streptococcus spp. showed the greatest resistance to 
tetracyclines (tetracycline and doxycycline), that does 
not allow to recommend these antibiotics as an effective 
starting therapy. 
The most effective antibiotics against Enterobac-
teriaceae are amikacin, ceftazidime, imipenem, cipro-
floxacin, ceftriaxone, and the least effective — amoxi-
cillin/clavulanic acid.
Conclusions
Maxillofacial inflammatory disease was a common 
cause of hospitalizations in the Department of Max-
illofacial Surgery in Belarus in 2014. Bacteriological 
testing seems to be a standard of care in this group 
of patients. According to the results of bacteriological 
examinations, the highest number of clinical isolates 
were identified in the inflammatory focus of the maxillo-
facial area in Mogilev, a few less in Gomel, Vitebsk and 
Grodno regional clinical hospitals, the lowest number 
— n Brest regional hospital.
At the present stage in Belarussian hospitals the 
main agents isolated from the inflammatory focus of 
the maxillofacial region are Streptococci, Staphylococci, 
Enterobacteria, which corresponds well with the global 
data. According to our analysis of pathogens antibiotic 
resistance, the following antibiotics for initial therapy, 
until receiving the results of bacteriological tests, can 
be recommended: clindamycin (effective against 
all studied pathogenic species), ceftriaxone, fluoro-
quinolones (ciprofloxacin). It is necessary to conduct 
further systematic monitoring of microflora in patients 
with maxillofacial inflammatory disease and study the 
bacterial antibiotic resistance in order to improve the 
treatment efficacy.
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